This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
furniture-retailers: Archive
Zacks.com featured highlights include Dycom Industries, Cimpress, The Marcus and Flexsteel Industries
by Zacks Equity Research
Rising cash flows put Dycom Industries and three other companies in focus as investors seek financially resilient stocks with improving earnings outlooks.
MCSNegative Net Change FLXSPositive Net Change DYNegative Net Change CMPRNegative Net Change
construction consumer-discretionary furniture-retailers
Should You Buy Crown Holdings (CCK) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
CCKPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Buy 4 Stocks With Rising Cash Flows to Enrich Your Portfolio
by Moumita C. Chattopadhyay
Dycom, Cimpress, Marcus and Flexsteel stand out as buy candidates after screening for rising cash flows, solid prices and strong VGM Scores.
MCSNegative Net Change FLXSPositive Net Change DYNegative Net Change CMPRNegative Net Change
construction consumer-discretionary furniture-retailers home-builder travel-leisure
Arhaus Stock Hinges on Margin Recovery, Demand Trends and Tech Savings
by Sumit Singh
Arhaus pairs record first-quarter revenue and showroom growth with tech savings, but weak written sales, tariffs and margin pressure cloud recovery.
ARHSNegative Net Change WSMPositive Net Change RHNegative Net Change
furniture-retailers
Is ARHS Stock a Buy Now or a Wait-and-See Retail Play?
by Sumit Singh
ARHS offers a reasonable valuation and debt-free balance sheet, but soft demand, margin pressure and tariff risks favor patience over an aggressive entry.
ARHSNegative Net Change WSMPositive Net Change RHNegative Net Change
furniture-retailers
Arhaus Stock Outlook Hinges on Growth Plans and Demand Recovery
by Sumit Singh
Arhaus pairs a differentiated brand and showroom expansion with improving demand, but margin pressure and tariff risks cloud the near-term outlook.
ARHSNegative Net Change WSMPositive Net Change RHNegative Net Change
furniture-retailers
New Analyst Coverage Puts These 5 Stocks in the Spotlight
by Shrabana Mukherjee
New analyst coverage puts BSET, GLAS, AROW, NRIM and JBSS in focus as investors seek stock-specific fundamentals amid macro uncertainty.
JBSSNegative Net Change AROWPositive Net Change NRIMPositive Net Change BSETPositive Net Change GLASPositive Net Change
consumer-staples finance furniture-retailers
Newsmax (NMAX) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
NMAXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
4 Top-Ranked Stocks With Solid Net Profit Margins to Boost Your Gains
by Anirudha Bhagat
Let's take a look at four stocks, FLXS, ARKO, KNSA and BSET, with impressive net profit margins for a robust portfolio.
FLXSPositive Net Change BSETPositive Net Change KNSAPositive Net Change ARKOPositive Net Change
furniture-retailers home-builder oil-energy pharmaceuticals
Should You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ABVXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines